oxybutynin has been researched along with Infection in 2 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Excerpt | Relevance | Reference |
---|---|---|
"Infections were associated with an increased risk of death (p < 0." | 2.84 | Infections Up to 76 Days After Stroke Increase Disability and Death. ( Bath, PM; Bereczki, D; Berge, E; Caso, V; Christensen, H; Collins, R; Czlonkowska, A; El Etribi, A; Farr, TD; Fone, KC; Gommans, J; Laska, AC; Learoyd, AE; Ntaios, G; Ozturk, S; Pocock, SJ; Prasad, K; Shaw, L; Sprigg, N; Trueman, RC; Wardlaw, JM; Woodhouse, L, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Learoyd, AE | 1 |
Woodhouse, L | 1 |
Shaw, L | 1 |
Sprigg, N | 1 |
Bereczki, D | 1 |
Berge, E | 1 |
Caso, V | 1 |
Christensen, H | 1 |
Collins, R | 1 |
Czlonkowska, A | 1 |
El Etribi, A | 1 |
Farr, TD | 1 |
Gommans, J | 1 |
Laska, AC | 1 |
Ntaios, G | 1 |
Ozturk, S | 1 |
Pocock, SJ | 1 |
Prasad, K | 1 |
Wardlaw, JM | 1 |
Fone, KC | 1 |
Bath, PM | 1 |
Trueman, RC | 1 |
Martínez, YN | 1 |
Cavello, I | 1 |
Hours, R | 1 |
Cavalitto, S | 1 |
Castro, GR | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Prospective, Collaborative, International, Multicentre, Randomised, Parallel-group, Single and Outcome Blinded, Controlled, Factorial Trial to Investigate the Safety and Efficacy of Treatment With Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, a[NCT00989716] | Phase 3 | 3,500 participants (Anticipated) | Interventional | 2001-07-31 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for oxybutynin and Infection
Article | Year |
---|---|
Infections Up to 76 Days After Stroke Increase Disability and Death.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Incidence; Infections; Male; Middle Aged; Nitroglyce | 2017 |
1 other study available for oxybutynin and Infection
Article | Year |
---|---|
Immobilized keratinase and enrofloxacin loaded on pectin PVA cryogel patches for antimicrobial treatment.
Topics: Administration, Topical; Anti-Infective Agents, Local; Cryogels; Enrofloxacin; Enzymes, Immobilized; | 2013 |